Literature DB >> 1391985

Prognostic factors in clinical trials.

S Dahlberg1, P Y Liu.   

Abstract

Prognostic factors define the study population, help formulate the study objectives, and influence the treatment strategies. They must be accounted for in the study analysis to obtain valid estimates of the treatment differences and to evaluate results across studies. The causal relationship between a prognostic factor and the study endpoint can only be established through prospective randomized study designs. Potential factors discovered through retrospective analysis must be verified to establish their validity. Using such factors prematurely to select patient population and treatment strategy for a new study will not establish the validity of the potentially important factor.

Entities:  

Mesh:

Year:  1992        PMID: 1391985     DOI: 10.1007/bf01840832

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  4 in total

1.  Covariate adjustment of treatment effects in clinical trials.

Authors:  P L Canner
Journal:  Control Clin Trials       Date:  1991-06

2.  Choosing covariates in the analysis of clinical trials.

Authors:  M L Beach; P Meier
Journal:  Control Clin Trials       Date:  1989-12

3.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

Authors:  S J Pocock; R Simon
Journal:  Biometrics       Date:  1975-03       Impact factor: 2.571

4.  Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.

Authors:  R A Badwe; W M Gregory; M A Chaudary; M A Richards; A E Bentley; R D Rubens; I S Fentiman
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

  4 in total
  2 in total

1.  DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese.

Authors:  K L Shen; C H Chu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

2.  Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is significantly lower in obese patients with early stage breast cancer.

Authors:  Umut Mousa; Handan Onur; Gungor Utkan
Journal:  Clin Transl Oncol       Date:  2012-07-25       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.